Santen Pharmaceutical Co. Ltd.
SNPHY | OTC
$11.23
+$0.45 (+4.17%)
At close: Oct 30, 2026, 3:15 PM ET
$11.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 80.88B | 93B | 94.58B | 57.9B | 83.01B | 62.89B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 19.94B | 16.18B | 24.41B | 37.36B | 36.24B | 37.07B |
Other Long-Term Assets | 13.72B | 10.36B | 8.99B | 5.2B | 4.71B | 3.87B |
Receivables | 71.83B | 72.08B | 90.54B | 107.17B | 99.59B | 95.99B |
Inventory | 64.58B | 51.59B | 43.19B | 39.35B | 37.14B | 41.58B |
Other Current Assets | 11.47B | 7.63B | 7.83B | 8.91B | 9.68B | 5.78B |
Total Current Assets | 228.76B | 224.3B | 236.14B | 213.33B | 229.43B | 206.23B |
Property-Plant & Equipment | 78.12B | 72.95B | 71.58B | 66.17B | 56.29B | 39.49B |
Goodwill & Intangibles | 71.66B | 75.47B | 83.82B | 96.31B | 130.22B | 115.81B |
Total Long-Term Assets | 194.28B | 184.98B | 199.56B | 207.85B | 230.55B | 199.05B |
Total Assets | 423.03B | 409.28B | 435.7B | 421.18B | 459.98B | 405.29B |
Account Payables | 35.35B | 38.99B | 24.04B | 25.28B | 24.42B | 24.26B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 306M | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 40.81B | 34.6B | 52.34B | 53.25B | 63.24B | 45.1B |
Total Current Liabilities | 87.87B | 86.84B | 92.8B | 89.5B | 95.82B | 78.55B |
Long-Term Debt | 27.34B | 26.48B | 27.46B | 28.2B | 12.68B | 944M |
Other Long-Term Liabilities | 7.93B | 2.97B | 3.01B | 3.64B | 5.82B | 6.23B |
Total Long-Term Liabilities | 39.15B | 37.26B | 37.53B | 38.38B | 27.31B | 17.09B |
Total Liabilities | 127.02B | 124.1B | 130.33B | 127.88B | 123.13B | 95.64B |
Total Debt | 34.75B | 33.96B | 35.16B | 35.96B | 22B | 10.15B |
Book Value | 296.02B | 285.18B | 305.37B | 293.3B | 336.84B | 309.64B |
Book Value Per Share | 901.46 | 815.52 | 829.49 | 757.05 | 841.14 | 773.36 |
Common Stock | 8.82B | 8.81B | 8.78B | 8.7B | 8.67B | 8.53B |
Retained Earnings | 223.29B | 228.29B | 240.03B | 238.07B | 290.48B | 273.24B |
Comprehensive Income | 56.26B | 40.51B | 48.41B | 37.78B | 29.69B | 20.44B |
Shareholders Equity | 296.99B | 286.24B | 306.05B | 293.98B | 337.49B | 310.18B |
Total Investments | 19.94B | 16.18B | 24.41B | 37.36B | 36.24B | 37.07B |
Add to Watchlist
Select watchlists to add or remove SNPHY